{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T18:27:08Z","timestamp":1790792828031,"version":"4.1.0"},"reference-count":18,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,5,22]],"date-time":"2021-05-22T00:00:00Z","timestamp":1621641600000},"content-version":"am","delay-in-days":386,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1016\/j.ijantimicag.2020.105909","type":"journal-article","created":{"date-parts":[[2020,1,25]],"date-time":"2020-01-25T11:35:05Z","timestamp":1579952105000},"page":"105909","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Resistance to third-generation cephalosporins in Escherichia coli in the French community: The times they are a-changin'?"],"prefix":"10.1016","volume":"55","author":[{"given":"Audrey","family":"Jeanvoine","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00e9l\u00e8ne","family":"Bouxom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joel","family":"Leroy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Houssein","family":"Gbaguidi-Haore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Bertrand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9line","family":"Slekovec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2020.105909_bib0001","series-title":"Surveillance of antimicrobial resistance in Europe 2017","year":"2017"},{"key":"10.1016\/j.ijantimicag.2020.105909_bib0002","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1007\/s11845-016-1538-z","article-title":"Antibiotic resistance patterns of Escherichia coli urinary isolates and comparison with antibiotic consumption data over 10 years, 2005\u20132014","volume":"186","author":"Stapleton","year":"2017","journal-title":"Ir J Med Sci"},{"key":"10.1016\/j.ijantimicag.2020.105909_bib0003","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1111\/j.1469-0691.2007.01850.x","article-title":"Prevalence and spread of extended-spectrum \u03b2-lactamase-producing Enterobacteriaceae in Europe","volume":"14","author":"Cant\u00f3n","year":"2008","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ijantimicag.2020.105909_bib0004","doi-asserted-by":"crossref","first-page":"3043","DOI":"10.1128\/AAC.00265-10","volume":"54","author":"Hawser","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2020.105909_bib0005","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.ijantimicag.2017.03.009","article-title":"Emerging extended-spectrum \u03b2-lactamase-producing Klebsiella pneumoniae causing community-onset urinary tract infections: a case\u2013control\u2013control study","volume":"50","author":"Boix-Palop","year":"2017","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2020.105909_bib0006","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.medmal.2017.09.013","article-title":"Antimicrobial resistance in community-acquired urinary tract infections in Paris in 2015","volume":"48","author":"Chervet","year":"2018","journal-title":"Med Mal Infect"},{"key":"10.1016\/j.ijantimicag.2020.105909_bib0007","doi-asserted-by":"crossref","first-page":"e02162","DOI":"10.1128\/mBio.02162-15","article-title":"Evolutionary history of the global emergence of the Escherichia coli epidemic clone ST131","volume":"7","author":"Stoesser","year":"2016","journal-title":"mBio"},{"issue":"Suppl 4","key":"10.1016\/j.ijantimicag.2020.105909_bib0008","doi-asserted-by":"crossref","first-page":"S341","DOI":"10.1086\/382690","article-title":"'Collateral damage' from cephalosporin or quinolone antibiotic therapy","volume":"38","author":"Paterson","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2020.105909_bib0009","series-title":"Anatomical Therapeutic Chemical (ATC) classification index with defined daily doses (DDDs)","year":"2001"},{"key":"10.1016\/j.ijantimicag.2020.105909_bib0010","unstructured":"Observatoire National de l'Epid\u00e9miologie de la R\u00e9sistance Bact\u00e9rienne aux Antibiotiques (ONERBA). 2017 Rapport d'activit\u00e9: Annual report. \u00c9dition Novembre 2018. ONERBA; 2018. http:\/\/onerba.org\/publications\/rapports-onerba\/[accessed 29 October 2019]."},{"key":"10.1016\/j.ijantimicag.2020.105909_bib0011","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.2147\/IDR.S160720","article-title":"The prevalence of plasmid-mediated quinolone resistance and ESBL-production in Enterobacteriaceae isolated from urinary tract infections","volume":"11","author":"Azargun","year":"2018","journal-title":"Infect Drug Resist"},{"key":"10.1016\/j.ijantimicag.2020.105909_bib0012","article-title":"Sequential acquisition of virulence and fluoroquinolone resistance has shaped the evolution of Escherichia coli ST131","volume":"7","author":"Ben Zakour","year":"2016","journal-title":"mBio"},{"key":"10.1016\/j.ijantimicag.2020.105909_bib0013","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1038\/ng.2478","article-title":"Emergence and global spread of epidemic healthcare-associated Clostridium difficile","volume":"45","author":"He","year":"2013","journal-title":"Nat Genet"},{"key":"10.1016\/j.ijantimicag.2020.105909_bib0014","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1101\/gr.147710.112","article-title":"A genomic portrait of the emergence, evolution, and global spread of a methicillin-resistant Staphylococcus aureus pandemic","volume":"23","author":"Holden","year":"2013","journal-title":"Genome Res"},{"key":"10.1016\/j.ijantimicag.2020.105909_bib0015","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.cmi.2017.06.018","article-title":"Global emergence of the widespread Pseudomonas aeruginosa ST235 clone","volume":"24","author":"Treepong","year":"2018","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ijantimicag.2020.105909_bib0016","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.medmal.2018.10.006","article-title":"Impact of a long-term antibiotic stewardship program targeting fluoroquinolones in a French local hospital","volume":"49","author":"Muller","year":"2019","journal-title":"Med Mal Infect"},{"key":"10.1016\/j.ijantimicag.2020.105909_bib0017","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2016.21.42.30376","article-title":"Prolonged colonisation with Escherichia coli O25:ST131 versus other extended-spectrum \u03b2-lactamase-producing E. coli in a long-term care facility with high endemic level of rectal colonisation, the Netherlands, 2013 to 2014","volume":"21","author":"Overdevest","year":"2016","journal-title":"Euro Surveill"},{"key":"10.1016\/j.ijantimicag.2020.105909_bib0018","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1038\/s41564-019-0410-0","article-title":"A nonlinear time-series analysis approach to identify thresholds in associations between population antibiotic use and rates of resistance","volume":"4","author":"L\u00f3pez-Lozano","year":"2019","journal-title":"Nat Microbiol"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857920300480?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857920300480?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T17:36:52Z","timestamp":1760377012000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857920300480"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5]]},"references-count":18,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,5]]}},"alternative-id":["S0924857920300480"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2020.105909","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2020,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Resistance to third-generation cephalosporins in Escherichia coli in the French community: The times they are a-changin'?","name":"articletitle","label":"Article Title"},{"value":"International Journal of Antimicrobial Agents","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2020.105909","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. and International Society of Chemotherapy. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"105909"}}